BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22605629)

  • 1. [Diagnostic and therapeutic update in narcolepsy].
    Santamaria-Cano J
    Rev Neurol; 2012 May; 54 Suppl 3():S25-30. PubMed ID: 22605629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics and treatment of narcolepsy.
    Dauvilliers Y; Tafti M
    Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
    Aran A; Einen M; Lin L; Plazzi G; Nishino S; Mignot E
    Sleep; 2010 Nov; 33(11):1457-64. PubMed ID: 21102987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narcolepsy-cataplexy and psychosis: a case study.
    Canellas-Dols F; Delgado C; Arango-Lopez C; Peraita-Adrados R
    Rev Neurol; 2017 Jul; 65(2):70-74. PubMed ID: 28675258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Narcolepsy: etiology, clinical features, diagnosis and treatment].
    Zawilska JB; Woldan-Tambor A; Płocka A; Kużajska K; Wojcieszak J
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():771-86. PubMed ID: 23175331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
    Dauvilliers Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narcolepsy.
    Kornum BR; Knudsen S; Ollila HM; Pizza F; Jennum PJ; Dauvilliers Y; Overeem S
    Nat Rev Dis Primers; 2017 Feb; 3():16100. PubMed ID: 28179647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for narcolepsy.
    Abad VC; Guilleminault C
    Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis of narcolepsy: from HLA association to hypocretin deficiency].
    Klein G; Burghaus L; Diederich N
    Fortschr Neurol Psychiatr; 2012 Nov; 80(11):627-34. PubMed ID: 22696207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy.
    Martínez-Rodríguez JE; Sabater L; Graus F; Iranzo A; Santamaria J
    Sleep; 2007 Jan; 30(1):27-8. PubMed ID: 17310861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.
    Lin JS; Dauvilliers Y; Arnulf I; Bastuji H; Anaclet C; Parmentier R; Kocher L; Yanagisawa M; Lehert P; Ligneau X; Perrin D; Robert P; Roux M; Lecomte JM; Schwartz JC
    Neurobiol Dis; 2008 Apr; 30(1):74-83. PubMed ID: 18295497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcolepsy-cataplexy associated with precocious puberty.
    Plazzi G; Parmeggiani A; Mignot E; Lin L; Scano MC; Posar A; Bernardi F; Lodi R; Tonon C; Barbiroli B; Montagna P; Cicognani A
    Neurology; 2006 May; 66(10):1577-9. PubMed ID: 16717224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypocretins/orexins and narcolepsy: from molecules to disease].
    Peyron C; Charnay Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S35-41. PubMed ID: 14646798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.